Status:
RECRUITING
Comparing the Efficacy of Steroid, Acupuncture and Platelet Rich Plasma Injection in Patients with Sciatica
Lead Sponsor:
Taipei Medical University Hospital
Conditions:
Sciatica
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Disc herniation, stenosis of the spine and spondylolisthesis are the common causes of radiculitis in medical practice today, and can cause symptoms of sciatica. Steroid injection, acupuncture and plat...
Detailed Description
Steroid injection, acupuncture and platelet-rich plasma injection are often used interventions for the treatments of sciatica. The investigators will investigate the efficacy and safety of steroid inj...
Eligibility Criteria
Inclusion
- Female or male, 20 to 80 years of age.
- Participants who had dermatome between L3 to S1, or participants whose straight leg raising test was positive, or participants had Meyerding Grade I to II spondylolisthesis or herniated intervertebral disc or spinal stenosis diagnosed by X-rays, Magnetic resonance imaging or computed tomography.
- Participants whose sciatica symptom doesn't have occur time limit.
- Participants who agreed to follow the trial protocol.
- Participants who could complete the study treatment and assessments.
- Participants who had steroid or pain control injection can participate the study after receiving injection more than 3 days.
Exclusion
- Participants with severe progressive neurological symptoms (e.g. cauda equina compression).
- Participants who had undergone surgery for lumbar disc herniation within 6 months.
- Participants whose sciatica symptom wasn't caused by lumbar radiculopathy.
- Participants with cardiovascular, liver, kidney, or hematopoietic system diseases, severe psychiatric or psychological disorder, or cancer.
- Women who were pregnant.
- Participants with a pacemaker, metal allergy, or severe fear of needles.
Key Trial Info
Start Date :
April 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 28 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03801512
Start Date
April 24 2019
End Date
May 28 2025
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, Taiwan, 11031